Literature DB >> 6381528

Production of bacteriocin-like inhibitors by group A streptococci of nephritogenic M types.

J R Tagg.   

Abstract

Application of a bacteriocin-typing scheme that had been designed to minimize the inhibitory effects of hydrogen peroxide and acidic metabolites demonstrated a high incidence (72%) of bacteriocin-like inhibitors belonging to 5 different production (P) types in 61 strains of group A streptococci isolated in association with the development of acute glomerulonephritis. By contrast, only 4 of 16 (25%) rheumatic fever-associated strains were inhibitor positive, and 3 of these strains were P type 604, a P type not detected in any of the nephritis isolates. The P type designation was found to be identical for all inhibitor-positive strains within each particular M serotype, regardless of whether the source was a nephritis patient or an individual having an uncomplicated streptococcal infection. The incidence of inhibitor-positive strains was particularly high in strains of M types 2, 4, 12, 25, 57, and 60; it was moderately high in M types 49, 52, and 55 and absent in M1 and M3. Although the results indicate that the bacteriocin-like inhibitors detected in this study are probably unlikely to have a direct pathogenetic role in either rheumatic fever or acute glomerulonephritis, it does seem that the present P-typing scheme is a useful epidemiological tool, particularly for the presumptive identification of and differentiation among group A streptococcus strains of nephritogenic serotypes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6381528      PMCID: PMC271204          DOI: 10.1128/jcm.19.6.884-887.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Streptococcin A-FF22: nisin-like antibiotic substance produced by a group A streptococcus.

Authors:  J R Tagg; L W Wannamaker
Journal:  Antimicrob Agents Chemother       Date:  1978-07       Impact factor: 5.191

2.  Bacteriocine-like activity of group-A streptococci due to the production of peroxide.

Authors:  H Malke; R Starke; H E Jacob; W Köhler
Journal:  J Med Microbiol       Date:  1974-08       Impact factor: 2.472

3.  Some possible autoimmune mechanisms in rheumatic carditis.

Authors:  J R Tagg; A R McGiven
Journal:  Lancet       Date:  1972-09-30       Impact factor: 79.321

4.  Biologic and immunologic comparison of nephritogenic and nonnephritogenic strains of group A, M-type 12 Streptococcus.

Authors:  R C Noble; K L Vosti
Journal:  J Infect Dis       Date:  1973-12       Impact factor: 5.226

5.  Production of streptocins by beta hemolytic streptococci with special reference to rheumatic heart diseases.

Authors:  P Aggarwal; K Prakash; K B Sharma
Journal:  J Commun Dis       Date:  1982-06

6.  M-type 57 group A streptococcus bacteriocin.

Authors:  W J Simpson; J R Tagg
Journal:  Can J Microbiol       Date:  1983-10       Impact factor: 2.419

7.  "Fingerprinting" beta-haemolytic streptococci by their production of and sensitivity to bacteriocine-like inhibitors.

Authors:  J R Tagg; L V Bannister
Journal:  J Med Microbiol       Date:  1979-11       Impact factor: 2.472

8.  Production of a bacteriocine-like substance by group-A streptococci of M-type 4 and T-pattern 4.

Authors:  D W Johnson; J R Tagg; L W Wannamaker
Journal:  J Med Microbiol       Date:  1979-11       Impact factor: 2.472

9.  Studies of the relationship between the production of bacteriocines by group A streptococci and acute glomerulonephritis.

Authors:  G D Overturf; E A Mortimer
Journal:  J Exp Med       Date:  1970-10-01       Impact factor: 14.307

10.  Production of bacteriocines by group A streptococci with special reference to the nephritogenic types.

Authors:  A G Kuttner
Journal:  J Exp Med       Date:  1966-09-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Yeast killer systems.

Authors:  W Magliani; S Conti; M Gerloni; D Bertolotti; L Polonelli
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Biotyping of bacterial isolates using the yeast killer system.

Authors:  G Morace; S Manzara; G Dettori; F Fanti; S Conti; L Campani; L Polonelli; C Chezzi
Journal:  Eur J Epidemiol       Date:  1989-09       Impact factor: 8.082

3.  Purification and characterization of streptin, a type A1 lantibiotic produced by Streptococcus pyogenes.

Authors:  Philip A Wescombe; John R Tagg
Journal:  Appl Environ Microbiol       Date:  2003-05       Impact factor: 4.792

4.  Role of proteinase in the formation of inhibitory levels of hematin by group A streptococcus cultures on blood-containing media.

Authors:  W L Hynes; J R Tagg
Journal:  J Clin Microbiol       Date:  1986-05       Impact factor: 5.948

5.  Production of the lantibiotic salivaricin A and its variants by oral streptococci and use of a specific induction assay to detect their presence in human saliva.

Authors:  Philip A Wescombe; Mathew Upton; Karen P Dierksen; Nancy L Ragland; Senthuran Sivabalan; Ruth E Wirawan; Megan A Inglis; Chris J Moore; Glenn V Walker; Chris N Chilcott; Howard F Jenkinson; John R Tagg
Journal:  Appl Environ Microbiol       Date:  2006-02       Impact factor: 4.792

6.  Inhibition of vaginal lactobacilli by a bacteriocin-like inhibitor produced by Enterococcus faecium 62-6: potential significance for bacterial vaginosis.

Authors:  Maureen C Kelly; Michael J Mequio; Vivien Pybus
Journal:  Infect Dis Obstet Gynecol       Date:  2003
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.